BIOQUAL, Inc.
BIOQ
$55.00
-$1.00-1.79%
OTC PK
| 11/30/2024 | 11/30/2023 | 11/30/2023 | 08/31/2023 | 05/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -79.51% | -46.11% | -46.11% | 228.12% | 38.40% |
| Total Depreciation and Amortization | -123.24% | -116.61% | -116.61% | -63.33% | 578.04% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -- | -- | -- | -- | -162.72% |
| Change in Net Operating Assets | -79.74% | 171.12% | 171.12% | -211.71% | 321.01% |
| Cash from Operations | -53.64% | 664.66% | 664.66% | -120.88% | 52.02% |
| Capital Expenditure | 92.80% | -142.88% | -142.88% | 90.60% | -24,381.25% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | 92.80% | -142.88% | -142.88% | 90.58% | -24,318.75% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | -- | -- | -- | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -64.69% | 541.74% | 541.74% | -128.93% | 19.94% |